These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29625303)

  • 1. Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center.
    Berchicci L; Rabiolo A; Marchese A; Iuliano L; Gigliotti C; Miserocchi E; Bandello F; Modorati G
    Ocul Surf; 2018 Jul; 16(3):314-321. PubMed ID: 29625303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.
    Giannaccare G; Bonifazi F; Sessa M; Dan E; Arpinati M; Fresina M; Bandini G; Cavo M; Versura P; Campos EC
    Eye (Lond); 2017 Oct; 31(10):1417-1426. PubMed ID: 28524885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation.
    Shikari H; Amparo F; Saboo U; Dana R
    Cornea; 2015 Mar; 34(3):243-7. PubMed ID: 25603230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
    Westeneng AC; Hettinga Y; Lokhorst H; Verdonck L; van Dorp S; Rothova A
    Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctival polyploid cells and donor-derived myofibroblasts in ocular GvHD.
    Hallberg D; Stenberg K; Hanson C; Stenevi U; Brune M
    Bone Marrow Transplant; 2016 May; 51(5):692-7. PubMed ID: 26808567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
    Khan R; Nair S; Seth T; Mishra P; Mahapatra M; Agarwal T; Tandon R; Vanathi M
    Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
    Trindade M; Rodrigues M; Pozzebon ME; Aranha FJP; Colella MP; Fernandes A; Fornazari DO; de Almeida Borges D; Vigorito AC; Alves M
    Sci Rep; 2022 Sep; 12(1):15926. PubMed ID: 36151252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination.
    Giannaccare G; Versura P; Bonifazi F; Sessa M; Campos EC
    Eye (Lond); 2019 Jan; 33(1):154-160. PubMed ID: 30194377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commensal microflora in human conjunctiva; characteristics of microflora in the patients with chronic ocular graft-versus-host disease.
    Shimizu E; Ogawa Y; Saijo Y; Yamane M; Uchino M; Kamoi M; Fukui M; Yang F; He J; Mukai S; Tsubota K
    Ocul Surf; 2019 Apr; 17(2):265-271. PubMed ID: 30742990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.
    Rapoport Y; Freeman T; Koyama T; Engelhardt BG; Jagasia M; Savani BN; Tran U; Kassim AA
    Cornea; 2017 Feb; 36(2):258-263. PubMed ID: 28060078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between Tear Film Osmolarity and the Disease Score of the International Chronic Ocular Graft-Versus-Host-Disease Consensus Group in Hematopoietic Stem Cell Transplantation Patients.
    Schargus M; Meyer-ter-Vehn T; Menrath J; Grigoleit GU; Geerling G
    Cornea; 2015 Aug; 34(8):911-6. PubMed ID: 26075459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye.
    Wang Y; Ogawa Y; Dogru M; Tatematsu Y; Uchino M; Kamoi M; Okada N; Okamoto S; Tsubota K
    Bone Marrow Transplant; 2010 Jun; 45(6):1077-83. PubMed ID: 19898506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model.
    Perez VL; Barsam A; Duffort S; Urbieta M; Barreras H; Lightbourn C; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1765-1772. PubMed ID: 27492793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study.
    Gavriilaki E; Christoforidi M; Ouranos K; Minti F; Mallouri D; Varelas C; Lazaridou A; Baldoumi E; Panteliadou A; Bousiou Z; Batsis I; Sakellari I; Gioula G
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.
    Riemens A; Te Boome LC; Kalinina Ayuso V; Kuiper JJ; Imhof SM; Lokhorst HM; Aniki R
    Acta Ophthalmol; 2014 Feb; 92(1):82-7. PubMed ID: 23601505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.
    Sun YC; Chai X; Inamoto Y; Pidala J; Martin PJ; Flowers ME; Shen TT; Lee SJ; Jagasia M
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1687-91. PubMed ID: 26033283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief account on ocular graft versus host disease.
    Chatterjee D
    Indian J Ophthalmol; 2023 Apr; 71(4):1115-1122. PubMed ID: 37026242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation.
    Na KS; Yoo YS; Mok JW; Lee JW; Joo CK
    Bone Marrow Transplant; 2015 Nov; 50(11):1459-64. PubMed ID: 26301966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
    Ijaz A; Khan AY; Malik SU; Faridi W; Fraz MA; Usman M; Tariq MJ; Durer S; Durer C; Russ A; Parr NNC; Baig Z; Sagar F; Ali Z; McBride A; Anwer F
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):94-99. PubMed ID: 30195074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle.
    Giannaccare G; Pellegrini M; Bernabei F; Scorcia V; Campos E
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1341-1351. PubMed ID: 30944986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.